ArticleJournal of arrhythmia2026
Efficacy and Safety of Catheter Ablation in Very Elderly Patients With Atrial Fibrillation: Short- To Mid-Term Outcomes From a Multicenter Study.
Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Catheter ablation has become a cornerstone of atrial fibrillation (AF) treatment. The prevalence of AF increases with age. However, research on catheter ablation in very elderly patients (age ≥ 80 years) is limited. This study aimed to assess the efficacy and safety of catheter ablation in very elderly patients with AF. Methods: We enrolled 150 very elderly patients (mean age, 82.2 ± 2.2 years, 84 men) who underwent catheter ablation for AF in 2018-2023. We assessed AF recurrence, periprocedural complications, and all-cause mortality. Results: One hundred (67%) patients had paroxysmal AF, and 136 (90.6%) underwent their first ablation for AF. At 2 years, the recurrence-free survival rate was 85.8% (95% confidence interval [CI], 78.2%-94.2%) in paroxysmal AF and 63.6% (95% CI, 48.9%-82.6%) in persistent AF ( Conclusions: Catheter ablation demonstrates reasonable efficacy and safety in very elderly patients with AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.